Effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal axis in neonatal clomipramine treated rats

J. Prathiba, K. B. Kumar, K. S. Karanth

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To study the effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis in neonatal clomipramine model of depression. Methods: Male rat pups were given clomipramine (15 mg/kg, s.c., twice daily) or equivolume of saline from the time they were five days old and until they were twenty-one days old. At three months of age, clomipramine treated rats were administered either imipramine (20 mg/kg, s.c.,) or saline once daily for 14 days. Serum corticosterone level was estimated before and after dexamethasone (100 μg/kg, s.c.,) administration in all animals. Results: Data indicated an enhanced baseline corticosterone level and nonsuppression to dexamethasone in clomipramine treated rats. The levels of corticosterone was reduced to the levels of control group in rats subjected to 14 days of imipramine treatment. Conclusion: Neonatal treatment of clomipramine produced dysregulation of HPA axis, and this neuroendocrine abnormality was reversed with chronic administration of imipramine.

Original languageEnglish
Pages (from-to)225-228
Number of pages4
JournalIndian Journal of Pharmacology
Volume31
Issue number3
Publication statusPublished - 01-06-1999
Externally publishedYes

Fingerprint

Clomipramine
Imipramine
Corticosterone
Dexamethasone
Control Groups
Serum

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{f59e4c89c5b9478684e633b35087ee11,
title = "Effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal axis in neonatal clomipramine treated rats",
abstract = "Objective: To study the effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis in neonatal clomipramine model of depression. Methods: Male rat pups were given clomipramine (15 mg/kg, s.c., twice daily) or equivolume of saline from the time they were five days old and until they were twenty-one days old. At three months of age, clomipramine treated rats were administered either imipramine (20 mg/kg, s.c.,) or saline once daily for 14 days. Serum corticosterone level was estimated before and after dexamethasone (100 μg/kg, s.c.,) administration in all animals. Results: Data indicated an enhanced baseline corticosterone level and nonsuppression to dexamethasone in clomipramine treated rats. The levels of corticosterone was reduced to the levels of control group in rats subjected to 14 days of imipramine treatment. Conclusion: Neonatal treatment of clomipramine produced dysregulation of HPA axis, and this neuroendocrine abnormality was reversed with chronic administration of imipramine.",
author = "J. Prathiba and Kumar, {K. B.} and Karanth, {K. S.}",
year = "1999",
month = "6",
day = "1",
language = "English",
volume = "31",
pages = "225--228",
journal = "Indian Journal of Pharmacology",
issn = "0253-7613",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

Effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal axis in neonatal clomipramine treated rats. / Prathiba, J.; Kumar, K. B.; Karanth, K. S.

In: Indian Journal of Pharmacology, Vol. 31, No. 3, 01.06.1999, p. 225-228.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal axis in neonatal clomipramine treated rats

AU - Prathiba, J.

AU - Kumar, K. B.

AU - Karanth, K. S.

PY - 1999/6/1

Y1 - 1999/6/1

N2 - Objective: To study the effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis in neonatal clomipramine model of depression. Methods: Male rat pups were given clomipramine (15 mg/kg, s.c., twice daily) or equivolume of saline from the time they were five days old and until they were twenty-one days old. At three months of age, clomipramine treated rats were administered either imipramine (20 mg/kg, s.c.,) or saline once daily for 14 days. Serum corticosterone level was estimated before and after dexamethasone (100 μg/kg, s.c.,) administration in all animals. Results: Data indicated an enhanced baseline corticosterone level and nonsuppression to dexamethasone in clomipramine treated rats. The levels of corticosterone was reduced to the levels of control group in rats subjected to 14 days of imipramine treatment. Conclusion: Neonatal treatment of clomipramine produced dysregulation of HPA axis, and this neuroendocrine abnormality was reversed with chronic administration of imipramine.

AB - Objective: To study the effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis in neonatal clomipramine model of depression. Methods: Male rat pups were given clomipramine (15 mg/kg, s.c., twice daily) or equivolume of saline from the time they were five days old and until they were twenty-one days old. At three months of age, clomipramine treated rats were administered either imipramine (20 mg/kg, s.c.,) or saline once daily for 14 days. Serum corticosterone level was estimated before and after dexamethasone (100 μg/kg, s.c.,) administration in all animals. Results: Data indicated an enhanced baseline corticosterone level and nonsuppression to dexamethasone in clomipramine treated rats. The levels of corticosterone was reduced to the levels of control group in rats subjected to 14 days of imipramine treatment. Conclusion: Neonatal treatment of clomipramine produced dysregulation of HPA axis, and this neuroendocrine abnormality was reversed with chronic administration of imipramine.

UR - http://www.scopus.com/inward/record.url?scp=0033021152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033021152&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 225

EP - 228

JO - Indian Journal of Pharmacology

JF - Indian Journal of Pharmacology

SN - 0253-7613

IS - 3

ER -